All News

What we're reading, December 30, 2015: most commonly used generic drugs were cheaper at the end of 2015, meanwhile the FDA has a huge backlog of generic drug applications, and few states are expected to expand Medicaid in 2016.

Stories about therapy, led by updates on Afrezza, were most popular with readers interested in diabetes care.

Puerto Rico’s community health centers face grave challenges because of a lack of funding.

How promoting the penalties of the individual mandates changes the sign-up mix, changing attitudes on women's pelvic health, and the challenges that await Louisiana's new governor as he plans to expand Medicaid.

After having launched a palliative care program in 2014, Cambia Health Solutions is now looking for ways to improve patient access to these tools that can improve a patient's quality of life.

An accompanying editorial says doctors are not irresponsible; they lack access to information about patients'prior overdoses.

The most read articles from The American Journal of Accountable Care explore the future of healthcare delivery as the United States moves to value-based care.

Patient awareness and educational support can improve their attitude as well as prepare them to make better informed decisions on clinical trial participation, a new study has found.

Moffitt Cancer Center said there's nothing wrong with the drug, but a spokesman said the trial is halted for now pending the outcome of the investigation.

What we're reading, December 28, 2015: patients fight for Medicaid coverage of expensive hepatitis C treatment, Express Scripts develops programs to protect insurer's from pricey new drugs, and Republicans divided over Medicaid expansion.

A new study published by the American Cancer Society found that younger colorectal cancer survivors end up spending over $8500 annually in medical expenses and they also experience significantly greater loss of productivity compared with individuals without cancer.

The prior CEO of MannKind attributed slow sales of Afrezza in part to slow reimbursement from insurers.

Study finds healthcare access was of paramount importance to people with chronic conditions and their caregivers.

John B. Watkins, PharmD, MPH, BCPS, pharmacy manager for formulary development at Premera Blue Cross, discussed using cost-effectiveness data for formulary decisions.

This week The American Journal of Managed Care offers a special episode of highlights from the American Society of Hematology's annual meeting, including sessions on newly approved treatments, how the move to pay-for-performance affects hematologists, and the increasing role of patient-reported outcomes.

In addition to being responsible for longer hospital stays and readmissions, Clostridium difficile is increases hospital costs by 40%, according to a new study conducted by Premier, Inc.

Most senior healthcare executives agreed that a healthcare system that embraces transparency will produce safer care and better outcomes, but a minority are happy with the current degree of transparency in their organization.

Emil Chiauzzi, PhD, research director, client services at PatientsLikeMe, sat down for an interview at the ISPOR 20th Annual International Meeting to discuss using social media for patient engagement and improving the relationships between researchers and patients.

What we're reading, December 25, 2015: a drug that is currently free could get very costly; this year's flu season is expected to be mild; and before they went on recess, members of Congress introduced a number of healthcare-related bills.

Top 10 videos from The American Journal of Managed Care's Summit and Insight programs.

St. Peter's University Hospital of New Brunswick argued that it will suffer irreparable harm if Horizon's OMNIA plan takes effect in the new year and it is not included in the preferred hospital tier.

A new study has provided the first strong evidence that warfarin can interact adversely with anti-diabetes drugs and cause serious hypoglycemic events.

Opioid prescribing patterns are far less skewed than initially thought. New research has found that most opioid prescriptions are actually distributed by the broad population of US general practitioners.

The rising cost of drugs was in the spotlight in 2015, and the manuscripts in The American Journal of Pharmacy Benefits highlights the growing concerns of the healthcare industry in regards to rising expenditures.

What we're reading, December 24, 2015: more than half of Affordable Care Act co-ops will be closed by the end of 2015, but this could have been avoided; 5 senators are pressing CMS for information on containing drug costs; and a task force does not recommend screening all teens and children for high cholesterol.

The new rule has been issued just as states are cracking down on the practice of balance billing patients who take steps to use in-network hospitals, only to be balanced billed anyway if they are seen by a provider not on their health plan.

With the Affordable Care Act endangered during the first half of 2015, many popular newsroom stories concerned President Obama's signature legislation.

It appears Sanofi will use a priority review voucher to catch up in the process to Novo Nordisk, which submitted an NDA for Xultophy in late September.

2.0 Credits - CPE | Expires 12/12/16

What we're reading, December 23, 2015: CMS releases data on the most expensive Medicare drugs, while HHS reports strong enrollment numbers on HealthCare.gov, and Hillary Clinton outlines a plan to spend $20 billion on Alzheimer's disease research.